|
|
||||||||
HOST RESPONSE TO INFECTION |
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61 Colindale Avenue, London, NW9 5HT and *Department of Biochemistry, Imperial College of Science, Technology and Medicine, South Kensington, London, SW7 2AY
Corresponding author: Dr H. Chart (e-mail hchart{at}phls.co.uk).
Received 23 April 1999; accepted 8 June 1999.
Abstract
Sera from patients infected with verocytotoxin-producing Escherichia coli (VTEC) O157, from patients with antibodies to E. coli O157 lipopolysaccharide (LPS) and from healthy controls were examined for antibodies to proteins involved in expressing the attaching and effacing phenotype. After SDS-PAGE, purified recombinant intimin, EspA-filament structural protein, translocated protein EspB and three separate domains of the translocated intimin receptor (Tir) were tested for reaction with patients' sera by immunoblotting. An ELISA was also used to detect antibodies to intimin in sera from E. coli O157 LPS antibody-positive individuals. Seven of nine culture-positive patients and one control patient had antibodies to EspA. Five of these patients and two controls had serum antibodies to the intimin-binding region of Tir, whereas none of the sera contained antibodies binding to either of the intracellular domains of Tir. By immunoblotting, 10 of 14 culture-positive patients had antibodies to the conserved region of intimin, eight of whom were infected with E. coli O157 phage type 2. Thirty-six of 60 sera from culture-negative but E. coli O157 LPS antibody-positive patients had antibodies to intimin as determined by ELISA. The secreted proteins are expressed in vivo during infection and are considered as pathogenic markers. Antibodies to these proteins may form the basis of a serodiagnostic test for the detection of patients infected with VTEC which carry the locus for the enterocyte effacement pathogenicity island and provide an adjunct test to the established serological tests based on VTEC LPS.
This article has been cited by other articles:
![]() |
L. Beutin, O. Marches, K. A. Bettelheim, K. Gleier, S. Zimmermann, H. Schmidt, and E. Oswald HEp-2 Cell Adherence, Actin Aggregation, and Intimin Types of Attaching and Effacing Escherichia coli Strains Isolated from Healthy Infants in Germany and Australia Infect. Immun., July 1, 2003; 71(7): 3995 - 4002. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Fitzhenry, S. Reece, L. R. Trabulsi, R. Heuschkel, S. Murch, M. Thomson, G. Frankel, and A. D. Phillips Tissue Tropism of Enteropathogenic Escherichia coli Strains Belonging to the O55 Serogroup Infect. Immun., August 1, 2002; 70(8): 4362 - 4368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. CHART, N. T. PERRY, T. CHEASTY, and P. A. WRIGHT The kinetics of antibody production to antigens of Escherichia coli O157 in a pregnant woman with haemolytic uraemic syndrome J. Med. Microbiol., June 1, 2002; 51(6): 522 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Shaw, S. Daniell, G. Frankel, and S. Knutton Enteropathogenic Escherichia coli translocate Tir and form an intimin-Tir intimate attachment to red blood cell membranes Microbiology, May 1, 2002; 148(5): 1355 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Paton and J. C. Paton Reactivity of Convalescent-Phase Hemolytic-Uremic Syndrome Patient Sera with the Megaplasmid-Encoded TagA Protein of Shiga Toxigenic Escherichia coli O157 J. Clin. Microbiol., April 1, 2002; 40(4): 1395 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J Fitzhenry, D J Pickard, E L Hartland, S Reece, G Dougan, A D Phillips, and G Frankel Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7 Gut, February 1, 2002; 50(2): 180 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghaem-Maghami, C. P. Simmons, S. Daniell, M. Pizza, D. Lewis, G. Frankel, and G. Dougan Intimin-Specific Immune Responses Prevent Bacterial Colonization by the Attaching-Effacing Pathogen Citrobacter rodentium Infect. Immun., September 1, 2001; 69(9): 5597 - 5605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, E. Frey, A. M. R. Mackenzie, and B. B. Finlay Human Response to Escherichia coli O157:H7 Infection: Antibodies to Secreted Virulence Factors Infect. Immun., September 1, 2000; 68(9): 5090 - 5095. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |